• Clayworth v. Pfizer, Inc.

    Publication Date: 2010-07-12
    Practice Area:
    Industry:
    Date Filed: 2010-07-12
    Court: Ca. Sup. Ct.
    Judge:
    Attorneys: For plaintiff: Attorneys for Appellant: Alioto Law Firm, Joseph M. Alioto, Joseph M. Alioto, Jr., Theresa D. Moore, Angelina Alioto-Grace, Thomas P. Pier; Law Offices of John H. Boone, John H. Boone; Foreman & Brasso, Russell F. Brasso; Law Offices of James M. Dombroski, James M. Dombroski; Law Offices of Jeffery K. Perkins, Jeffrey K. Perkins; Gary D. McCallister & Associates, Gary D. McCallister, Thomas A. Kelliher, Eric I. Unrein and Jaime Goldstein for Plaintiffs and Appellants. Coughlin Stoia Geller Rudman & Robbins, Pamela M. Parker; Schubert Jonckheer Kolbe & Kralowec and Kimberly A. Kralowec for Consumer Attorneys of California as Amicus Curiae on behalf of Plaintiffs and Appellants. Zelle Hofmann Voelbel & Mason, Craig C. Corbitt and Henry A. Cirillo for Pharmacists Planning Services, Inc., as Amicus Curiae on behalf of Plaintiffs and Appellants.
    for defendant: Attorneys for Respondent: Filice Brown Eassa & McLeod, Peter A. Strotz, Paul R. Johnson, William E. Steimle; Davis Polk & Wardwell, Ameila Starr, Arthur F. Golden, William J. Fenrich and Daniel J. Schwartz for Defendant and Respondent AstraZeneca LP. Winston & Strawn, Tyler M. Paetkau, Nicole P. Dogwill, James F. Hurst, Susan A. Pipal, Matthew J. Sullivan; Eimer Stahl Klevorn & Solberg, David M. Stahl, J. Cunyon Gordon and Adam Oyenbanji for Defendant and Respondent Abbott Laboratories. Gibson, Dunn & Crutcher, Jeffrey T. Thomas and James N. Knight for Defendant and Respondent Allergan, Inc. Mayer, Brown, Rowe & Maw, Mayer Brown, Donald M. Falk, John Nadolenco, Mack Anderson; Sheppard Mullin Richter & Hampton, Steven O. Kramer, John P. Stigi III; Hogan & Hartson and Joseph H. Young for Defendant and Respondent Amgen, Inc. Covington & Burling, Elizabeth Abigail Brown, Anita F. Stork, Theodore Voorhees, Jr., and Thomas J. Cosgrove for Defendant and Respondent Boehringer Ingelheim Pharmaceuticals, Inc. Sedgwick, Detert, Moran & Arnold, Paul J. Riehle, Matthew A. Fischer; Cravath, Swaine & Moore, Evan R. Chesler, Elizabeth L. Grayer, Jessica Buturla and Jeffrey B. Korn for Defendant and Respondent Bristol-Myers Squibb Company. Reed Smith, Michael Diane Floyd, Kirsten J. Handelman; Oppenheimer Wolff & Donnelly, Gary Hansen, David Graham and Aaron Mills Scott for Defendant and Respondent Eli Lilly & Company. Irell & Manella, Alexander F. Wiles, John C. Keith; Cleary Gottlieb Steen & Hamilton, George S. Cary, Sara D. Schotland and David I. Gelfand for Defendant and Respondent GlaxoSmithKline PLC. Drinker Biddle & Reath, H. Christian L?Orange, Paul H. Saint-Antoine, Mary E. Kohart, David J. Antczak and Joanne C. Lewers for Defendant and Respondent Hoffmann-La Roche Inc. Folger Levin & Kahn, Crowell & Moring, Beatrice Bich-Dao Nguyen, Samuel Ray Miller, Tracy E. Reichmuth, Cecilia C. Ogbu, Steven E. Wilson; Patterson Belknap Webb & Tyler, William Cavanaugh, Jr., and Cecilia B. Loving for Defendants and Respondents Janssen Pharmaceutica Inc., Johnson & Johnson Health Care Systems, Inc., Ortho Biotech, Inc., and Ortho-McNeil Pharmaceutical, Inc. Hughes Hubbard & Reed, Rita M. Haeusler, John M. Townsend, Scott H. Christensen, James A. Graffam; Orrick, Herrington & Sutcliffe, Robert P. Reznick and David Goldstein for Defendant and Respondent Merck Sharp & Dohme Corp. formerly known as Merck & Co., Inc. Kaye Scholer, Aton Arbisser, Bryant S. Delgadillo, Saul P. Morgenstern, Karin E. Garvey; Faegre & Benson, James A. O?Neal and Kim J. Walker for Defendant and Respondent Novartis Pharmaceuticals Corporation. Nossaman, Gunther, Knox & Elliott, Nossaman, Scott DeVries, Katrina June Lee; Dickstein Shapiro, Peter J. Kadzik, Bernard Nash, Maria Colsey Heard, Milton Marquis and Andres Colin for Defendant and Respondent Pfizer Inc. Latham & Watkins, Charles H. Samel, Jennifer A. Carmassi, Margaret M. Zwisler, Steven H. Schulman and Belinda S. Lee for Defendant and Respondent Pharmaceutical Research and Manufacturers of America. Arnold & Porter, Ronald C. Redcay, Douglas L. Wald, Mark R. Merley, Daniel R. Waldman, Anne P. Davis and Ryan Z. Watts for Defendant and Respondent Wyeth.

    Case Number: No. S166435

    Cite as 10 C.D.O.S. 87895JAMES CLAYWORTH et al., Plaintiffs and Appellants, v. PFIZER, INC., et al., Def

  • August 5, 2009 | The American Lawyer

    Which Firms Did Layoffs Well -- and Which Didn't?

    On a Monday morning in early March, two associates sat in an East Coast office of Morgan, Lewis & Bockius discussing a firmwide e-mail fro

    1 minute read

  • April 4, 2011 | The Recorder

    Monthly Lateral Report

    California lateral partner movements in March 2011 Part

    1 minute read

  • Gleason v. Norwest Mortgage, Inc.

    Publication Date: 2001-03-13
    Practice Area:
    Industry:
    Date Filed: 2001-03-09
    Court: 3rd Cir.
    Judge: Rosenn, Circuit Judge.
    Attorneys: For plaintiff:
    for defendant:

    Case Number: 00-5112

    Argued: October 6, 2000Filed: March 9, 2001OPINION OF THE COURTThis multi-issue appeal has its origin in the sale of a company subject to an apparently simple "right of first offer." Cristen

  • July 19, 1999 | National Law Journal

    Non-Affirmative Actions

    As black corporate America gets richer, black law firms are standing outside with their noses pressed against the windowpane. Black lawyers, particularly members of the National Bar Associat

    1 minute read

  • December 10, 2009 | The Recorder

    Heller Leaders Saw Failure Looming, Documents Show

    Heller Ehrman's leaders discussed the firm's "mortality" while assuring partners it was sound, and recruited more than five merger candidates by early 2008, including Mintz Levin, accordi

    1 minute read

  • December 10, 2009 | The Recorder

    Heller Leaders Saw Failure Looming

    Update (10am Thursday): Heller creditors pencil settlement with junior partners (

    1 minute read

  • January 31, 2011 | Corporate Counsel

    Getting Fired: Don't Deal With the In-House Counsel and Deal With It Publicly?

    This is the kind of bad review that in-house counsel never want to hear. Although, hey, it's impossible to please everybody right? Waaaaaay back in May 2008, Paul Hastings fired senio

    1 minute read